David Albagli, PhD is a Local Partner in White & Case's Global Intellectual Property Practice, based in Tokyo. His practice focuses on intellectual property spanning patent litigation, prosecution, opinion work and patent portfolio strategy development as well as pre-litigation counseling and due diligence investigations. Dr. Albagli advises on a wide range of intellectual property matters in the pharmaceutical, chemical, and biotechnology sectors.
Dr. Albagli has extensive experience advising Japanese and foreign clients on securing and enforcing patent rights in the US and coordinating patent strategies across multiple countries and regions.
He has hands-on experience as a patent attorney and scientist in a wide range of fields, particularly in chemistry, nucleic acid technologies, in vitro diagnostics, electrochemistry, microfluidics, polymers, and biochemistry. He is a frequent speaker, in English and Japanese, on patent and intellectual property issues, and writes extensively on these issues. He is a member of Daiichi Tokyo Bar Association, American Intellectual Property Law Association (AIPLA), International Association for the Protection of Intellectual Property of Japan (AIPPI Japan), Licensing Executives Society International (LESI), and The Tokyo IP American Inn of Court. He is appointed to editorial board by International Association for the Protection of Intellectual Property of Japan (AIPPI Japan) from April 2019.
Representation of Magnum Opus Acquisition Limited on its business combination with Asia Innovations Group Limited, a leading mobile social company serving emerging markets. The transaction provides for a total equity valuation of US$2.5 billion.
"Cross-Border Litigation and Compliance Strategies for 2019", November 6 and 8, 2018: TAIWAN SYMPOSIUM, Taipei and Hsinchu
"Pharmaceutical Patents – ANDA and Biosimilars Litigation in the US", July 6, 2018: Keio University Law School, Tokyo
"Digital Healthcare & Legal Trends, Risks, and Opportunities", 20 June, 2018: 36th Healthcare Seminar, "Connected Health", Pharma Delegates, Tokyo
"PCT Applications: Strategies and Tips at the International and National Stages", October 14, 2017: The Japan Patent Attorneys Association, Tokyo
"Patents & Pharma: An Ever-Changing Global Landscape", October 12, 2017: Life Sciences Patent Network Asia 2017 (LSPN 2017), Singapore
"2017 Pharma Innovation Development Program: Recent Trends in the US and Japan Regarding Life Sciences and a Globalizing Workforce", January 21, 2017: Tokyo Interdisciplinary Life Science Consortium, Tokyo
"2016 'Invention Day' Memorial Lecture", April 20, 2016: Japan Foods & Biotechnology Intellectual Property Rights Center (JAFBIC), Tokyo
"US Patent Seminar- Basic Course", October 30 – December 25, 2014: Toshiba Techno Center, Tokyo
"Establishing Support for Claims and Claim Amendments with the Specification and Post-Filing Data" and "Trends in Post-Grant Procedures under the AIA", April 15, 2014: First Annual "Invention Day" Conference, JAFBIC, Tokyo
"The Evolving Legal Landscape for Patent Protection of Stem Cells", April 13-15, 2013: The 6th Pan Pacific Symposium on Stem Cells and Cancer Research by Taiwan Neurosurgical Society, Hsinchu, Taiwan
Japan Patent Act Amendment: How to Compensate Inventors Now?, Lexology, July 8, 2016, (Co-author)
Prior User Rights in Japan: They Can't Take That Away from Me, Financier Worldwide Global Reference Guide 2012: Intellectual Property, September 2012, (Co-author)
"The Fastest Routes for Green Patents", Managing Intellectual Property, August 2012, (Co-author)
Strategies for Litigating False Marking Cases, Daily Journal, March 30, 2010, (Co-author)
Might No One Have Standing to Bring Suit?, IP Law 360, November 2007, (Co-author)